Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders

NCT02063945 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER_GOV

Sponsor class

Stopped Major difficulties recruiting participants

Conditions

Attention Deficit/Hyperactivity Disorder
Oppositional Defiant Disorder
Conduct Disorder

Interventions

DRUG: Methylphenidate
DRUG: Risperidone

Sponsor

Sheba Medical Center